Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online July 1, 2020.
Article Versions
- Latest version (June 8, 2020 - 04:00).
- You are currently viewing a Latest version of this article (July 1, 2020 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2020 The Journal of Rheumatology
Author Information
- Randy Q. Cron and
- W. Winn Chatham
- From the University of Alabama at Birmingham, Department of Pediatrics, Division of Rheumatology; Department of Medicine, Division of Clinical Immunology and Rheumatology, Birmingham, Alabama, USA. Address correspondence to Dr. R.Q. Cron, Children’s of Alabama, Division of Rheumatology, 1600 7th Ave. S., CPPN, suite G10, Birmingham, Alabama 35233-1711, USA. E-mail: rcron@peds.uab.edu. Drs. Cron and Chatham are co-principal investigators on an investigator-initiated clinical trial to study interleukin 1 blockade in treating secondary hemophagocytic lymphohistiocytosis in children and adults. The trial is funded by Swedish Orphan Biovitrum Inc. (SOBI; ClinicalTrials.gov: NCT02780583), which manufactures anakinra. Dr. Cron serves as a consultant to SOBI. Dr. Chatham has served as a consultant to SOBI.